TrialThe Lancet. Respiratory medicine2016

Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial.

Donald P Tashkin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.